Interleukin-18 in acute ischaemic stroke patients.
As proinflammatory cytokines released during ischaemia are detrimental to the brain, the study aimed to evaluate serum interleukin-18 (IL-18) levels in stroke patients and to investigate the relation between these and epidemiological and clinical data. The study comprised 23 ischaemic stroke patients and 15 controls. Blood sampling for IL-18 determination and for chemistry, and brain CT were performed within 24 h of stroke, while neurological stroke severity and functional disability were estimated, respectively, with the Scandinavian stroke scale (SSS) and Barthel index (BI) within the same interval and two weeks later. There were higher serum IL-18 levels in stroke patients. These correlated with erythrocyte sedimentation rate (ESR), brain CT hypodense area volumes, and SSS and BI scores calculated at both studied times. Moreover, IL-18 levels were higher in patients with non-lacunar stroke subtype than in those with lacunar strokes. The results suggest that IL-18 is involved in stroke-induced inflammation and that initial serum IL-18 levels may be predictive of stroke outcome.
Zaremba
J
J
Department of Clinical Neuroimmunology, Section of Neurology, University School of Medicine, 49 Przybyszewskiego Street, PL-60-355 Poznan, Poland.
Losy
J
J
D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D004185:Disability Evaluation; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006261:Headache / Q000097:blood; D006801:Humans; D020382:Interleukin-18 / Q000097:blood*; D007511:Ischemia / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013223:Statistics as Topic; D020521:Stroke / Q000097:blood*; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D020382:Interleukin-18